BIM
VNDA icon

Bogle Investment Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Bogle Investment Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-43,954
Closed -$425K – 269
2020
Q3 		$425K Buy
43,954
+4,325
+11% +$46.2K 0.12% 167
2020
Q2 		$453K Sell
39,629
-173,811
-81% -$1.97M 0.08% 216
2020
Q1 		$2.21M Sell
213,440
-18,293
-8% -$227K 0.23% 127
2019
Q4 		$3.8M Buy
231,733
+15,797
+7% +$239K 0.36% 96
2019
Q3 		$2.87M Buy
+215,936
New +$3.01M 0.25% 111
2019
Q1 		– Sell
-196,471
Closed -$5.13M – 390
2018
Q4 		$5.13M Sell
196,471
-9,683
-5% -$228K 0.4% 96
2018
Q3 		$4.73M Buy
206,154
+64,272
+45% +$1.31M 0.34% 99
2018
Q2 		$2.7M Sell
141,882
-89,849
-39% -$1.5M 0.2% 132
2018
Q1 		$3.9M Sell
231,731
-92,266
-28% -$1.54M 0.29% 105
2017
Q4 		$4.92M Sell
323,997
-28,607
-8% -$425K 0.36% 98
2017
Q3 		$6.31M Buy
+352,604
New +$5.9M 0.43% 94
2017
Q2 		– Sell
-69,527
Closed -$973K – 378
2017
Q1 		$973K Sell
69,527
-381,320
-85% -$5.43M 0.07% 226
2016
Q4 		$7.19M Sell
450,847
-78,229
-15% -$1.26M 0.5% 74
2016
Q3 		$8.8M Buy
+529,076
New +$7.12M 0.63% 58
2014
Q2 		– Sell
-606,489
Closed -$9.86M – 388
2014
Q1 		$9.86M Sell
606,489
-326,139
-35% -$4.64M 0.68% 53
2013
Q4 		$11.6M Buy
932,628
+329,284
+55% +$3.31M 0.98% 12
2013
Q3 		$6.61M Sell
603,344
-368,639
-38% -$3.94M 0.67% 51
2013
Q2 		$7.85M Buy
+971,983
New +$6.55M 0.96% 13

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bogle Investment Management's VNDA Position: Q4 2020 in Review

Bogle Investment Management sold out of Vanda Pharmaceuticals (VNDA) in Q4 2020, closing a stake of 43,954 shares — an estimated $425K sold.

Bogle Investment Management first reported a position in VNDA in Q2 2013 and held it in 18 quarters. The position peaked at $11.6M in Q4 2013. 178 funds tracked by Wall St. Rank hold VNDA as of Q4 2020.

  • Bogle Investment Management reported no remaining Vanda Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Bogle Investment Management sold 43,954 Vanda Pharmaceuticals shares in Q4 2020, an estimated $425K.
  • Bogle Investment Management first reported a position in Vanda Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Bogle Investment Management's Vanda Pharmaceuticals position peaked at $11.6M in Q4 2013.
  • 178 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2020.

Based on Bogle Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.